Standout Papers

Angiogenesis in cancer and other diseases 1996 2026 2006 2016 7.1k
  1. Angiogenesis in cancer and other diseases (2000)
    Peter Carmeliet, Rakesh K. Jain Nature
  2. Molecular mechanisms and clinical applications of angiogenesis (2011)
    Peter Carmeliet, Rakesh K. Jain Nature
  3. Angiogenesis in health and disease (2003)
    Peter Carmeliet Nature Medicine
  4. Mechanisms of angiogenesis and arteriogenesis (2000)
    Peter Carmeliet Nature Medicine
  5. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele (1996)
    Peter Carmeliet, Valérie Ferreira et al. Nature
  6. Angiogenesis in life, disease and medicine (2005)
    Peter Carmeliet Nature
  7. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (1998)
    Peter Carmeliet, Yuval Dor et al. Nature
  8. Basic and Therapeutic Aspects of Angiogenesis (2011)
    Michael Potente, Holger Gerhardt et al. Cell
  9. Hypoxia and Inflammation (2011)
    Holger K. Eltzschig, Peter Carmeliet New England Journal of Medicine
  10. VEGF as a Key Mediator of Angiogenesis in Cancer (2005)
    Peter Carmeliet Oncology
  11. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases (2011)
    Peter Carmeliet, Rakesh K. Jain Nature Reviews Drug Discovery
  12. Phenotype molding of stromal cells in the lung tumor microenvironment (2018)
    Diether Lambrechts, Els Wauters et al. Nature Medicine
  13. uPAR: a versatile signalling orchestrator (2002)
    Francesco Blasi, Peter Carmeliet Nature Reviews Molecular Cell Biology
  14. Physiological consequences of loss of plasminogen activator gene function in mice (1994)
    Peter Carmeliet, Luc Schoonjans et al. Nature
  15. Common mechanisms of nerve and blood vessel wiring (2005)
    Peter Carmeliet, Marc Tessier‐Lavigne Nature
  16. COVID-19: the vasculature unleashed (2020)
    Laure-Anne Teuwen, Vincent Geldhof et al. Nature reviews. Immunology
  17. Gene prioritization through genomic data fusion (2006)
    Stein Aerts, Diether Lambrechts et al. Nature Biotechnology
  18. Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels (2007)
    Christian Fischer, Bart Jonckx et al. Cell
  19. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis (2004)
    Karel De Gendt, Johannes V. Swinnen et al. Proceedings of the National Academy of Sciences
  20. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling (2001)
    Olivier Nicole, Fabián Docagne et al. Nature Medicine
  21. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice (2002)
    Veerle Compernolle, Koen Brusselmans et al. Nature Medicine
  22. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization (1998)
    Khalid Bajou, Agnès Noël et al. Nature Medicine
  23. Role of tissue factor in embryonic blood vessel development (1996)
    Peter Carmeliet, Nigel Mackman et al. Nature
  24. Molecular mechanisms of lymphangiogenesis in health and disease (2002)
    Kari Alitalo, Peter Carmeliet Cancer Cell
  25. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation (1997)
    Peter Carmeliet, Lieve Moons et al. Nature Genetics
  26. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 (1999)
    Peter Carmeliet, Yin‐Shan Ng et al. Nature Medicine
  27. Endothelial Cell Metabolism in Normal and Diseased Vasculature (2015)
    Guy Eelen, Pauline de Zeeuw et al. Circulation Research
  28. Tumour hypoxia causes DNA hypermethylation by reducing TET activity (2016)
    Bernard Thienpont, Jessica Steinbacher et al. Nature
  29. FOXO1 couples metabolic activity and growth state in the vascular endothelium (2016)
    Kerstin Wilhelm, Guy Eelen et al. Nature
  30. Endothelial Cell Metabolism (2017)
    Guy Eelen, Pauline de Zeeuw et al. Physiological Reviews
  31. Basic and Therapeutic Aspects of Angiogenesis Updated (2020)
    Guy Eelen, Lucas Treps et al. Circulation Research
  32. Immunomodulation by endothelial cells — partnering up with the immune system? (2022)
    Jacob Amersfoort, Guy Eelen et al. Nature reviews. Immunology
  33. Understanding tumour endothelial cell heterogeneity and function from single-cell omics (2023)
    Qun Zeng, Mira Mousa et al. Nature reviews. Cancer
  34. Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition (2023)
    Daniel Jiménez-Blasco, Jesús Agulla et al. Nature Metabolism
  35. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges (2023)
    Xiaoyi Yuan, Wei Ruan et al. Nature Reviews Drug Discovery

Immediate Impact

67 by Nobel laureates 61 from Science/Nature 221 standout
Sub-graph 1 of 15

Citing Papers

Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
The changing landscape of atherosclerosis
2021 StandoutNature
2 intermediate papers

Works of Peter Carmeliet being referenced

Endothelial Cell Metabolism in Health and Disease
2017
Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
1995
and 2 more

Author Peers

Author Last Decade Papers Cites
Peter Carmeliet 52350 27080 8171 14817 720 98.1k
Judah Folkman 62209 29198 6807 24238 391 103.7k
Napoleone Ferrara 60705 23583 3192 20350 257 97.7k
Zena Werb 45042 33138 7853 34757 411 108.4k
Lewis C. Cantley 103801 29279 4853 27070 702 148.2k
Roderick T. Bronson 45554 11505 3607 22954 543 76.8k
Gregg L. Semenza 63518 68202 4466 15314 418 114.8k
George D. Yancopoulos 54500 11822 3096 14103 425 101.4k
Craig B. Thompson 90608 43942 4682 24948 513 148.6k
Ronald A. DePinho 55409 13587 2838 22760 416 84.9k
John C. Reed 72596 12113 3291 21174 788 106.2k

All Works

Loading papers...

Rankless by CCL
2026